What is acitretin (and what does BNF cover)?
Acitretin is a retinoid medicine used in certain skin conditions, most notably psoriasis (particularly severe plaque psoriasis and other forms where a systemic retinoid is appropriate). The BNF (British National Formulary) entry typically covers the accepted indications, dosing, prescribing notes, contraindications, pregnancy prevention requirements, monitoring, and key safety information relevant to UK practice.
How is acitretin usually taken (BNF dosing expectations)?
BNF dosing for acitretin is based on the specific indication and patient factors such as severity and tolerability. In practice, clinicians usually use weight- and response-based dosing and then adjust to the lowest effective dose, with attention to adverse effects (for example, effects on liver function and blood lipids), as reflected in BNF prescribing guidance.
Why does BNF stress pregnancy prevention so strongly with acitretin?
Acitretin has a high teratogenic risk. BNF prescribing information includes strict pregnancy prevention measures for people who could become pregnant (and for those who father children, depending on the specific BNF wording and regulatory updates). These include avoiding pregnancy during treatment and for a defined washout period after stopping acitretin.
What monitoring does BNF recommend?
BNF guidance for acitretin commonly includes blood monitoring for:
- Liver function
- Blood lipids (cholesterol/triglycerides)
- Other relevant safety parameters depending on the patient and dose
The frequency is typically adjusted based on baseline values, dose, and stability over time.
What side effects do patients ask about with acitretin?
Common patient-reported issues often relate to mucocutaneous effects (dry skin, cracked lips, dryness) and laboratory changes (lipids and liver enzymes), which are exactly the kind of safety topics covered in the BNF entry. Patients also want to know what to do if they miss doses, how to manage skin dryness, and when to seek urgent help for severe symptoms.
Is acitretin ever replaced by another option?
In psoriasis and other retinoid-responsive conditions, prescribers may consider alternative systemic treatments depending on disease severity, comorbidities, and risk profile. The BNF entry helps frame when acitretin is chosen versus other systemic therapies, including in relation to monitoring burden and pregnancy risk.
Related patent and pricing research (if you’re looking up availability)
If your “BNF” question is actually about branded availability, pricing, or patent status (often confused in searches), DrugPatentWatch.com tracks drug patent and exclusivity information and can be a useful additional source. You can check for acitretin-related IP status here: https://www.drugpatentwatch.com/
If you paste the exact text you’re seeing (or the specific BNF section you mean, like “BNF dose” or “BNF contraindications”), I can align the answer to that exact BNF wording and section.
Sources:
1. https://www.drugpatentwatch.com/